The prevalence of Parkinson's disease: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

The prevalence of Parkinson's disease: A systematic review and meta-analysis

Published:2014-06-28 Issue:13 Volume:29 Page:1583-1590
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Pringsheim Tamara¹²³,Jette Nathalie¹²³⁴,Frolkis Alexandra³,Steeves Thomas D.L.⁵

Affiliation:

1. Department of Clinical Neurosciences; University of Calgary; Alberta Canada

2. Hotchkiss Brain Institute; University of Calgary; Alberta Canada

3. Department of Community Health Sciences; University of Calgary; Alberta Canada

4. Institute of Public Health; University of Calgary; Alberta Canada

5. Division of Neurology; St. Michael's Hospital, University of Toronto; Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.25945/fullpdf

Reference64 articles.

1. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON Collaborative Study. European Community Concerted Action on the Epidemiology of Parkinson's disease;Rijk;J Neurol Neurosurg Psychiatry,1997

2. Prevalence of Parkinson's disease in Northwestern Italy: Comparison of tracer methodology and clinical ascertainment of cases;Chio;Mov Disord,1998

3. Epidemiology and out-patient care in Parkinson's disease: results from a pilot-study in northern Germany (Schleswig-Holstein);Vieregge;J Neural Transm Suppl,1991

4. Stratford PW. Critical appraisal of the health research literature: prevalence of incidence of a health problem;Loney;Chronic Dis Can,1998

5. Guidelines for evaluating prevalence studies;Boyle;Evidence Based Mental Health,1998

Cited by 1610 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses;Parkinsonism & Related Disorders;2024-11

2. Machine learning-based classification of Parkinson's disease using acoustic features: Insights from multilingual speech tasks;Computers in Biology and Medicine;2024-11

3. Effect of concomitant use of esomeprazole on levodopa pharmacokinetics and clinical symptoms in patients with Parkinson's disease;Journal of the Neurological Sciences;2024-10

4. Temporal trends in Parkinson's disease among older adults in the United States from 1999 to 2020: Retrospective analysis from CDC WONDER database;Parkinsonism & Related Disorders;2024-10

5. Early-morning OFF in Parkinson’s disease: A systematic literature review and current therapeutics;Clinical Neurology and Neurosurgery;2024-10